Sublime

Announcing Biomni — the first general-purpose biomedical AI agent. Biomni is a free web platform where biomedical scientists can immediately delegate their tasks to Biomni, starting today! Biomni automates literature reviews, hypothesis generation, protocol design, bioinformatics analysis, clinical reasoning, and much... See more

My lab has developed a CAR T cell therapy that targets a glycoform of fibronectin in a peptidic epitope encoded by exon 40 of FN1. Yesterday I learned that exon 40 is differentially spliced in AA cancers of multiple histotypes. We now have CARs to address health disparities.

growing crop of biotech newco's that are leveraging china preclin execution (not just CROs) coupled with US translational bio + clinical trial design mostly working in genetic medicines, but also in ADCs and antibodies funded by mostly non-US biotech VCs, although a couple exceptions... See more

We’re excited to introduce Chai-2, a major breakthrough in molecular design. Chai-2 enables zero-shot antibody discovery in a 24-well plate, exceeding previous SOTA by >100x. Thread👇 https://t.co/CnO6vO7VmX

We’re excited to share the results of our first pharmaceutical process in microgravity today. Our processing hardware performed flawlessly. Our mission is to now enable cost-effective high-cadence access to enable next-generation therapeutics. Our results and... See more

Can LLM agents discover novel protein functions? Introducing Gaia Agent 🌎 🤖: an AI biologist capable of reasoning across genomic contexts to predict functions of proteins! Gaia Agent is now integrated with Gaia Search at https://t.co/WGpulaJE25 https://t.co/OqAayynHSt